The Green Room: A Podcast from Obstetrics & Gynecology

Dr. Asha N. Talati, an expert in maternal fetal medicine and genetic counseling at UNC, joins to discuss the latest advancements in pregnancy management for individuals with cystic fibrosis. They explore the impact of effective modulator therapies on fertility and reduced preterm birth risks. The conversation highlights innovations in prenatal care, including randomized trials on postpartum hemorrhage and the genetic considerations affecting maternal health. Critical ethical questions surrounding expensive treatments and the importance of informed counseling are also addressed.

Dr. Asha N. Talati, an assistant professor specializing in maternal fetal medicine and clinical genetics at UNC, delves into groundbreaking research on managing pregnancy in cystic fibrosis patients. She discusses the transformative effects of highly effective modulator therapies on pregnancy outcomes. The conversation covers prenatal genetic counseling, the ethical implications of fetal treatment, and the balancing act of breastfeeding while on medication. Dr. Talati emphasizes the importance of informed reproductive planning for both parents and healthcare providers.

Discover innovative approaches to managing urinary tract infections, particularly in light of rising cases post-COVID. Explore the latest research on uterine leiomyomas and cervical cancer outcomes. An enlightening discussion on pain management reveals the potential of transcutaneous electrical nerve stimulation during endometrial biopsies. Despite its effectiveness showing modest results, high patient satisfaction suggests a promising future. Tune in for insights into empowering patients and fostering healthier urogenital microbiomes.

In this engaging discussion, Dr. Caroline M. Mitchell shares her expertise as a research faculty at Harvard and director of the Vulvovaginal Disorders Program. The conversation delves into the complexities of vaginitis, emphasizing the need for accurate diagnosis through lab testing. Dr. Mitchell highlights personalized treatment approaches for recurrent infections like bacterial vaginosis and candidiasis, addressing antifungal resistance. She also discusses advancements in treatment options for trichomoniasis and the importance of nurturing a healthy vaginal microbiome.

Dr. Naida M. Cole, an Assistant Professor and chief of the OB anesthesia division at the University of Chicago, dives into critical discussions on maternal health equity and the impact of healthcare policies on maternal outcomes. She highlights innovative approaches to managing uterine atony and postpartum hemorrhage, including insights from her research on second-line uterotonics. The conversation also addresses ACOG's recent guideline updates, particularly in shared decision-making for patient care, and the implications of recent clinical trials in obstetric practices.

Ebony Carter, a reproductive health equity researcher and associate professor at UNC School of Medicine, shares her expertise on diabetes in pregnancy. She discusses the benefits of group prenatal care over traditional methods, highlighting improved postpartum engagement and disparities in outcomes. The conversation explores the challenges of transitioning to virtual care during the pandemic and the importance of adapting practices based on patient needs. Carter's insights shed light on the evolving landscape of prenatal care and the necessity for evidence-based approaches.

Dive into the latest advancements in managing diabetes during pregnancy, where expert insights highlight the role of continuous glucose monitoring in improving outcomes. Discover innovative diagnostic methods for hyperglycemia, focusing on the urgent need for early detection. A new multi-center trial aims to shed light on glucose metabolism's impact on pregnancy. The discussion underscores the significance of research in transforming prenatal care and enhancing the health of both mothers and babies.

Courtney Kerestes, a complex family planning specialist at The Ohio State University and author on innovative abortion-related research, joins the discussion. She introduces the LMP-SURE self-screening tool that allows patients to assess eligibility for medication abortion without unnecessary ultrasounds. The talk also dives into a multi-site study reviewing this method's impressive accuracy and the significant role of period tracking apps in enhancing LMP dating. This conversation highlights the need for patient-centered approaches in gynecological care.

Jennifer Hoskovec, VP of Clinical Affairs at Billion to One, dives into the latest breakthroughs in prenatal testing. She discusses the rise of personalized management for hemolytic disease, emphasizing non-invasive methods and cell-free DNA technology to enhance patient care. The conversation highlights a pivotal study on nipocalumab's potential to treat severe neonatal conditions and introduces innovative algorithms for managing red blood cell isoimmunization. With a focus on collaboration and accuracy, Hoskovec shares insights that could reshape obstetric practices.

Dr. Torri D. Metz, an associate professor and maternal-fetal medicine expert at the University of Utah, shares key insights on managing mild chronic hypertension during pregnancy. She discusses the benefits of elective induction at 39 weeks, emphasizing tailored delivery approaches for better maternal and fetal health. The conversation also covers innovative postpartum monitoring practices and the importance of research for improved outcomes, including findings from the significant CHAP trial on blood pressure management for pregnant individuals.